New Leaf Venture Partners, L.L.C. Passage Bio, Inc. Transaction History
New Leaf Venture Partners, L.L.C.
- $96.9 Million
- Q3 2024
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Passage Bio, Inc. stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 2,497,922 shares of PASG stock, worth $1.62 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
2,497,922
Previous 2,497,922
-0.0%
Holding current value
$1.62 Million
Previous $1.97 Million
11.4%
% of portfolio
1.8%
Previous 2.4%
Shares
1 transactions
Others Institutions Holding PASG
# of Institutions
47Shares Held
38.7MCall Options Held
7.7KPut Options Held
0-
Orbimed Advisors LLC San Diego, CA9.82MShares$6.38 Million0.16% of portfolio
-
Lynx1 Capital Management LP San Juan, PR8.43MShares$5.48 Million2.11% of portfolio
-
Vestal Point Capital, LP New York, NY6.1MShares$3.97 Million0.32% of portfolio
-
Erste Asset Management Gmb H Vienna, C42.46MShares$1.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$1.35 Million0.0% of portfolio
About Passage BIO, Inc.
- Ticker PASG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,463,200
- Market Cap $35.4M
- Description
- Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...